EZRA Innovations' Incubator/Accelerator Round

EZRA Innovations raised a round of funding on , . Investors include UAMS Arkansas BioVentures.

EZRA Innovations currently holds exclusive worldwide rights in a controlled-release drug delivery system. Drug Surfactant Complex (DSC) Deoxycholate is used in combination with active pharmaceutical i…

Articles about EZRA Innovations' Incubator/Accelerator Round: